Preventing Type 2 Diabetes in Black Emergent Adult
1 other identifier
interventional
100
1 country
1
Brief Summary
Black Americans are disproportionately affected by diabetes, with nearly double the rates of type 2 diabetes mellitus (T2DM), compared to non-Hispanic White adults. Though numerous factors affect these disparities, one modifiable risk factor may be that of binge eating (BE), which increases risk for binge-eating disorder (BED), which is associated with severe obesity, and often precedes a T2DM diagnosis, beginning in childhood or adolescence. Nearly 30% of Black women with obesity report binge eating episodes. Furthermore, given that binge and overeating may disparately increase the odds of obesity in Black adults (15-fold increase vs. 6-fold increase in White adults), reducing this behavior will be critical to prevent continued disparities in T2DM diagnosis. Given that Black women have the highest rates of obesity in the nation (57%), report disparate rates of weight gain between young adulthood and mid adulthood, and report disparate rates of emotional eating in adolescence, which is a risk factor for BE, one pathway to reducing disparities in T2DM risk in Black women may be to reduce binge eating and prevent weight gain in emerging adulthood (ages 18-25).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes-mellitus
Started Jun 2025
Longer than P75 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2025
CompletedFirst Posted
Study publicly available on registry
February 26, 2025
CompletedStudy Start
First participant enrolled
June 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
July 30, 2025
July 1, 2025
5.4 years
February 14, 2025
July 28, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in number of Binge Eating Episodes from Baseline to Month 6
Participants will self-monitor and complete surveys on binge eating episodes.
Baseline, 6 months
Change from Baseline to Month 6 in weight regain
Participant body weight will be measured by trained research staff using calibrated digital scales. Participants will be in light indoor clothing, with pockets emptied, and belts and shoes removed.
Baseline, 6 months
Secondary Outcomes (1)
Change in Inflammatory Biomarkers for T2DM from Baseline to Month 6
Baseline, 6 months
Study Arms (2)
Appetite Awareness Training (AAT) and Diabetes Prevention Program (DPP)
EXPERIMENTALParticipants are randomized into the AAT and DPP groups and receive content from both programs for 12 months.
Diabetes Prevention Program (DPP) only
EXPERIMENTALParticipants are randomized into the DPP group and will be able to access the program's content.
Interventions
Partcipants will receive the AAT delivered as 16 core sessions over six months as well as six maintenance sessions over the course of 12 months.
Partcipants will receive the DPP delivered as 16 core sessions over six months as well as six maintenance sessions over the course of 12 months.
Eligibility Criteria
You may qualify if:
- Black women
- between 18-25 years of age
- BMI ≥ 25 kg/m\^2
- At least one binge eating episode weekly
- Prediabetic
- Have access to a smartphone
You may not qualify if:
- Have no internet access
- Currently type 2 diabetic
- Currently pregnant
- Are in substance use treatment
- Have received prior or planned bariatric surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UNC-Chapel Hill
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel Goode, PhD,MPH,LCSW
University of North Carolina, Chapel Hill
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2025
First Posted
February 26, 2025
Study Start
June 30, 2025
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
July 30, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share